Our Global Life Sciences M&A team were invited by Financier Worldwide, a leading, widely respected information source covering corporate finance and board-level business issues to provide their views on the life sciences M&A market for the upcoming November issue. The topics covered in the Q&A include deal appetite, regulatory changes, FDI, managing transactional risk, pre and post deal strategies, and the future of the market.
***************
This article was first published by Financier Worldwide Ltd
©2023 Financier Worldwide Ltd. All rights reserved.
Permission to use this reprint has been granted by the publisher.
***************
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-10-08-10-50-28-575-67050e74c71f57809f6d0411.jpg)
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-12-20-00-19-07-074-6764b7fb8b43d2162bbda63e.jpg)
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-12-17-10-04-22-244-67614ca6e47d4e3f62efe626.jpg)
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-12-16-09-34-16-975-675ff418f1680c6c88e5b5fa.jpg)
/Passle/596df0e43d947619ec025f26/MediaLibrary/Document/2024-12-10-12-27-55-733-A26208_Life_Sciences_Brochure_November_Brochure_English_V1_thumbnail_1.png)
